Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-25

FDA Approved: PRAMIPEXOLE DIHYDROCHLORIDE — Supplemental Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved a supplemental application for pramipexole dihydrochloride (Ingenus Pharmaceuticals) under an ANDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pramipexole dihydrochloride (pramipexole dihydrochloride)

Snippet

SUPPL AP for PRAMIPEXOLE DIHYDROCHLORIDE (PRAMIPEXOLE DIHYDROCHLORIDE)